{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:15:13Z","timestamp":1769112913328,"version":"3.49.0"},"reference-count":48,"publisher":"e-Century Publishing Corporation","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/hrdh6927","type":"journal-article","created":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:05:06Z","timestamp":1759039506000},"page":"7058-7066","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a nomogram for predicting moderate-to-severe pain in hepatitis B virus-related liver cancer patients after CyberKnife treatment"],"prefix":"10.62347","volume":"17","author":[{"given":"Yating","family":"Chi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","article-title":"Immunobiology and pathogenesis of hepatitis B virus infection","volume":"22","author":"Iannacone","year":"2022","unstructured":"Iannacone M and Guidotti LG. Immunobiology and pathogenesis of hepatitis B virus infection. Nat Rev Immunol 2022; 22: 19-32.","journal-title":"Nat Rev Immunol"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Adugna A. Histomolecular characterisation of hepatitis B virus induced liver cancer. Rev Med Virol 2023; 33: e2485.","DOI":"10.1002\/rmv.2485"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jhep.2024.06.037","article-title":"Hepatitis B virus DNA integration: implications for diagnostics, therapy, and outcome","volume":"81","author":"Zoulim","year":"2024","unstructured":"Zoulim F, Chen PJ, Dandri M, Kennedy PT and Seeger C. Hepatitis B virus DNA integration: implications for diagnostics, therapy, and outcome. J Hepatol 2024; 81: 1087-1099.","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jcmgh.2023.01.001","article-title":"Hepatitis B virus DNA integration drives carcinogenesis and provides a new biomarker for HBV-related HCC","volume":"15","author":"Yeh","year":"2023","unstructured":"Yeh SH, Li CL, Lin YY, Ho MC, Wang YC, Tseng ST and Chen PJ. Hepatitis B virus DNA integration drives carcinogenesis and provides a new biomarker for HBV-related HCC. Cell Mol Gastroenterol Hepatol 2023; 15: 921-929.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1152987","DOI":"10.3389\/fcimb.2023.1152987","article-title":"Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response","volume":"13","author":"Yan","year":"2023","unstructured":"Yan F, Zhang Q, Shi K, Zhang Y, Zhu B, Bi Y and Wang X. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response. Front Cell Infect Microbiol 2023; 13: 1152987.","journal-title":"Front Cell Infect Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Liu Y, Kim ES and Guo H. Hepatitis B virus-related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures. J Med Virol 2024; 96: e29485.","DOI":"10.1002\/jmv.29485"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/gutjnl-2020-323153","article-title":"Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma","volume":"71","author":"Peneau","year":"2022","unstructured":"Peneau C, Imbeaud S, La Bella T, Hirsch TZ, Caruso S, Calderaro J, Paradis V, Blanc JF, Letouze E, Nault JC, Amaddeo G and Zucman-Rossi J. Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma. Gut 2022; 71: 616-626.","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1097\/CM9.0000000000003171","article-title":"Survey of hepatitis B virus infection for liver cancer screening in China: a population-based, cross-sectional study","volume":"137","author":"Xu","year":"2024","unstructured":"Xu Y, Xia C, Li H, Cao M, Yang F, Li Q, Cao M and Chen W. Survey of hepatitis B virus infection for liver cancer screening in China: a population-based, cross-sectional study. Chin Med J (Engl) 2024; 137: 1414-1420.","journal-title":"Chin Med J (Engl)"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Ibrahim MK, Liu CD, Zhang L, Yu X, Kim ES, Liu Z, Jo S, Liu Y, Huang Y, Gao SJ and Guo H. The loss of hepatitis B virus receptor NTCP\/SLC10A1 in human liver cancer cells is due to epigenetic silencing. J Virol 2024; 98: e0118724.","DOI":"10.1128\/jvi.01187-24"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"101360","DOI":"10.1016\/j.coviro.2023.101360","article-title":"Hepatitis-B virus: replication cycle, targets, and antiviral approaches","volume":"63","author":"Nasser","year":"2023","unstructured":"Nasser N, Tonnerre P, Mansouri A and Asselah T. Hepatitis-B virus: replication cycle, targets, and antiviral approaches. Curr Opin Virol 2023; 63: 101360.","journal-title":"Curr Opin Virol"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Wongtrakul W, Charoenngam N, Ponvilawan B, Rujirachun P, Wattanachayakul P, Srikulmontri T, Hong N, Rai P and Ungprasert P. Hepatitis B virus infection and risk of gastric cancer: a systematic review and meta-analysis. Minerva Gastroenterol (Torino) 2023; 69: 546-552.","DOI":"10.23736\/S2724-5985.21.02946-6"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.3390\/v15122359","article-title":"Regulation of mitochondrial metabolism by hepatitis B virus","volume":"15","author":"Li","year":"2023","unstructured":"Li Y and Ou JJ. Regulation of mitochondrial metabolism by hepatitis B virus. Viruses 2023; 15: 2359.","journal-title":"Viruses"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Low WF, Ngeow YF, Chook JB, Tee KK, Ong SK, Peh SC, Bong JJ and Mohamed R. Hepatitis B virus DNA methylation and its potential role in chronic hepatitis B. Expert Rev Mol Med 2022; 25: e11.","DOI":"10.1017\/erm.2022.38"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1141956","DOI":"10.3389\/fimmu.2023.1141956","article-title":"Hepatitis B virus infection: an insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk","volume":"14","author":"Min","year":"2023","unstructured":"Min Y, Wei X, Xia X, Wei Z, Li R, Jin J, Liu Z, Hu X and Peng X. Hepatitis B virus infection: an insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk. Front Immunol 2023; 14: 1141956.","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-3-030-57362-1_3","article-title":"Mechanisms of hepatitis B virus-induced hepatocarcinogenesis","volume":"217","author":"Lee","year":"2021","unstructured":"Lee J, Tsai KN and Ou JJ. Mechanisms of hepatitis B virus-induced hepatocarcinogenesis. Recent Results Cancer Res 2021; 217: 47-70.","journal-title":"Recent Results Cancer Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/1754-9485.13527","article-title":"Role of stereotactic body radiotherapy for inferior vena cava tumour thrombus in hepatocellular carcinoma","volume":"67","author":"Sharma","year":"2023","unstructured":"Sharma D, Thaper D, Kamal R and Yadav HP. Role of stereotactic body radiotherapy for inferior vena cava tumour thrombus in hepatocellular carcinoma. J Med Imaging Radiat Oncol 2023; 67: 444-449.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.29271\/jcpsp.2021.05.532","article-title":"Cyberknife radiosurgery in hepatocellular carcinoma","volume":"31","author":"Memon","year":"2021","unstructured":"Memon B, Kadri S, Sultana N, Saeed K, Ahmed N and Mahmood T. Cyberknife radiosurgery in hepatocellular carcinoma. J Coll Physicians Surg Pak 2021; 31: 532-536.","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12885-016-2512-x","article-title":"Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma","volume":"16","author":"Que","year":"2016","unstructured":"Que J, Kuo HT, Lin LC, Lin KL, Lin CH, Lin YW and Yang CC. Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma. BMC Cancer 2016; 16: 451.","journal-title":"BMC Cancer"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00701-018-3504-1","article-title":"Clinical features of brain metastases from hepatocellular carcinoma using gamma knife surgery","volume":"160","author":"Ogino","year":"2018","unstructured":"Ogino A, Hirai T, Serizawa T and Yoshino A. Clinical features of brain metastases from hepatocellular carcinoma using gamma knife surgery. Acta Neurochir (Wien) 2018; 160: 997-1003.","journal-title":"Acta Neurochir (Wien)"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Zeng Z, Han Y, Li W, Chen H, Lin N, Yu Y and Xu X. Baseline FIB-4 may be a risk factor of recurrence after SBRT in patients with HBV-related small HCC. Cancer Med 2025; 14: e70535.","DOI":"10.1002\/cam4.70535"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Zeng M, Tang Z, Ren L, Wang H, Wang X, Zhu W, Mao X, Li Z, Mo X, Chen J, Han J, Kong D, Ji J, Carr AM and Liu C. Hepatitis B virus infection disrupts homologous recombination in hepatocellular carcinoma by stabilizing resection inhibitor ADRM1. J Clin Invest 2023; 133: e171533.","DOI":"10.1172\/JCI171533"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.cgh.2021.06.019","article-title":"Risk of hepatitis B virus reactivation in patients treated with immunotherapy for anti-cancer treatment","volume":"20","author":"Yoo","year":"2022","unstructured":"Yoo S, Lee D, Shim JH, Kim KM, Lim YS, Lee HC, Yoo C, Ryoo BY and Choi J. Risk of hepatitis B virus reactivation in patients treated with immunotherapy for anti-cancer treatment. Clin Gastroenterol Hepatol 2022; 20: 898-907.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/jvh.13551","article-title":"Hepatitis B virus-induced hepatocarcinogenesis: a virological and oncological perspective","volume":"28","author":"Arslan","year":"2021","unstructured":"Arslan F, Franci G, Maria Nastri B and Pagliano P. Hepatitis B virus-induced hepatocarcinogenesis: a virological and oncological perspective. J Viral Hepat 2021; 28: 1104-1109.","journal-title":"J Viral Hepat"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1079495","DOI":"10.3389\/fimmu.2023.1079495","article-title":"Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma","volume":"14","author":"Sun","year":"2023","unstructured":"Sun R, Li J, Lin X, Yang Y, Liu B, Lan T, Xiao S, Deng A, Yin Z, Xu Y, Xiang Z and Wu B. Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma. Front Immunol 2023; 14: 1079495.","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"104938","DOI":"10.1016\/j.meegid.2021.104938","article-title":"Increased hepatitis B virus quasispecies diversity is correlated with liver fibrosis progression","volume":"93","author":"Wu","year":"2021","unstructured":"Wu H, Liao B, Li X, Liu H, Gong M, Shi H, Xie S, Guo F, Chen K, Yan R, Zhao H, Li L, Zheng A, Liu Y and Wang Z. Increased hepatitis B virus quasispecies diversity is correlated with liver fibrosis progression. Infect Genet Evol 2021; 93: 104938.","journal-title":"Infect Genet Evol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3892\/mmr.2021.12025","article-title":"MicroRNA-1271-5p alleviates the malignant development of hepatitis B virus-mediated liver cancer via binding to AQP5","volume":"23","author":"Li","year":"2021","unstructured":"Li Z, Ma L, Di L and Lin X. MicroRNA-1271-5p alleviates the malignant development of hepatitis B virus-mediated liver cancer via binding to AQP5. Mol Med Rep 2021; 23: 386.","journal-title":"Mol Med Rep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.3748\/wjg.v29.i14.2188","article-title":"Acoustic radiation force impulse predicts long-term outcomes in a large-scale cohort: high liver cancer, low comorbidity in hepatitis B virus","volume":"29","author":"Tai","year":"2023","unstructured":"Tai J, Harrison AP, Chen HM, Hsu CY, Hsu TH, Chen CJ, Jeng WJ, Chang ML, Lu L and Tai DI. Acoustic radiation force impulse predicts long-term outcomes in a large-scale cohort: high liver cancer, low comorbidity in hepatitis B virus. World J Gastroenterol 2023; 29: 2188-2201.","journal-title":"World J Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3350\/cmh.2021.0355","article-title":"Cause of death and cause-specific mortality for primary liver cancer in South Korea: a nationwide population-based study in hepatitis B virus-endemic area","volume":"28","author":"Kim","year":"2022","unstructured":"Kim BH, Lee D, Jung KW, Won YJ and Cho H. Cause of death and cause-specific mortality for primary liver cancer in South Korea: a nationwide population-based study in hepatitis B virus-endemic area. Clin Mol Hepatol 2022; 28: 242-253.","journal-title":"Clin Mol Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Pujol F, Jaspe RC, Loureiro CL and Chemin I. Hepatitis B virus American genotypes: pathogenic variants? Clin Res Hepatol Gastroenterol 2020; 44: 825-835.","DOI":"10.1016\/j.clinre.2020.04.018"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2421231","DOI":"10.1080\/21505594.2024.2421231","article-title":"Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma","volume":"15","author":"Zhang","year":"2024","unstructured":"Zhang Y, Cao W, Wang S, Zhang L, Li X, Zhang Z, Xie Y and Li M. Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma. Virulence 2024; 15: 2421231.","journal-title":"Virulence"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.3748\/wjg.v27.i24.3556","article-title":"Current impact of viral hepatitis on liver cancer development: the challenge remains","volume":"27","author":"de Mattos","year":"2021","unstructured":"de Mattos AZ, Debes JD, Boonstra A, Yang JD, Balderramo DC, Sartori GDP and de Mattos AA. Current impact of viral hepatitis on liver cancer development: the challenge remains. World J Gastroenterol 2021; 27: 3556-3567.","journal-title":"World J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3350\/cmh.2020.0324","article-title":"Old hepatitis B virus never dies: it just hides itself within the host genome","volume":"27","author":"Lee","year":"2021","unstructured":"Lee JH. Old hepatitis B virus never dies: it just hides itself within the host genome. Clin Mol Hepatol 2021; 27: 107-109.","journal-title":"Clin Mol Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Qiu S, Jin L, Yang D and Zhang D. Clinical application value of hepatitis B virus basal core promoter 1762\/1764 and GGTII and GGT in patients with HBV-DNA-positive primary liver cancer. Medicine (Baltimore) 2023; 102: e35699.","DOI":"10.1097\/MD.0000000000035699"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1080\/07391102.2020.1830852","article-title":"Using structural analysis to explore the role of hepatitis B virus mutations in immune escape from liver cancer in Chinese, European and American populations","volume":"40","author":"Gu","year":"2022","unstructured":"Gu S, Lv L, Lin X, Li X, Dai J, Zhang J, Kong R, Xie W and Li J. Using structural analysis to explore the role of hepatitis B virus mutations in immune escape from liver cancer in Chinese, European and American populations. J Biomol Struct Dyn 2022; 40: 1586-1596.","journal-title":"J Biomol Struct Dyn"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s12275-022-2371-x","article-title":"Hepatitis B virus (HBV) codon adapts well to the gene expression profile of liver cancer: an evolutionary explanation for HBV’s oncogenic role","volume":"60","author":"Yu","year":"2022","unstructured":"Yu C, Li J, Li Q, Chang S, Cao Y, Jiang H, Xie L, Fan G and Wang S. Hepatitis B virus (HBV) codon adapts well to the gene expression profile of liver cancer: an evolutionary explanation for HBV’s oncogenic role. J Microbiol 2022; 60: 1106-1112.","journal-title":"J Microbiol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/v13020180","article-title":"Hepatitis B virus DNA integration: in vitro models for investigating viral pathogenesis and persistence","volume":"13","author":"Tu","year":"2021","unstructured":"Tu T, Zhang H and Urban S. Hepatitis B virus DNA integration: in vitro models for investigating viral pathogenesis and persistence. Viruses 2021; 13: 180.","journal-title":"Viruses"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"4964","DOI":"10.3390\/ijms24054964","article-title":"Relevance of HBx for hepatitis B virus-associated pathogenesis","volume":"24","author":"Schollmeier","year":"2023","unstructured":"Schollmeier A, Glitscher M and Hildt E. Relevance of HBx for hepatitis B virus-associated pathogenesis. Int J Mol Sci 2023; 24: 4964.","journal-title":"Int J Mol Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"6225403","DOI":"10.1155\/2021\/6225403","article-title":"Big data information under proportional hazard mathematical model in analysis of hepatitis B virus infection data of patients with interventional liver cancer through antiviral therapy of entecavir","volume":"2021","author":"Zhang","year":"2021","unstructured":"Zhang Y, Zhao S, Ding H, Song X, Miao H, Cui X, Wang J and Han B. Big data information under proportional hazard mathematical model in analysis of hepatitis B virus infection data of patients with interventional liver cancer through antiviral therapy of entecavir. J Healthc Eng 2021; 2021: 6225403.","journal-title":"J Healthc Eng"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"934","DOI":"10.2174\/1386207324666210816141436","article-title":"Exploring the effect of polyphyllin I on hepatitis B virus-related liver cancer through network pharmacology and in vitro experiments","volume":"25","author":"Yu","year":"2022","unstructured":"Yu S, Gao W, Zeng P, Chen C, Liu Z, Zhang Z and Liu J. Exploring the effect of polyphyllin I on hepatitis B virus-related liver cancer through network pharmacology and in vitro experiments. Comb Chem High Throughput Screen 2022; 25: 934-944.","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/09553002.2022.2094020","article-title":"Radiotherapy for bone metastases of hepatocellular carcinoma: a hybrid systematic review with meta-analyses","volume":"99","author":"Rim","year":"2023","unstructured":"Rim CH, Park S, Yoon WS, Shin IS and Park HC. Radiotherapy for bone metastases of hepatocellular carcinoma: a hybrid systematic review with meta-analyses. Int J Radiat Biol 2023; 99: 419-430.","journal-title":"Int J Radiat Biol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jhep.2020.09.026","article-title":"radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trial","volume":"74","author":"Kim","year":"2021","unstructured":"Kim TH, Koh YH, Kim BH, Kim MJ, Lee JH, Park B and Park JW. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trial. J Hepatol 2021; 74: 603-612.","journal-title":"J Hepatol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/S1470-2045(24)00438-8","article-title":"Palliative radiotherapy versus best supportive care in patients with painful hepatic cancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 study","volume":"25","author":"LA","year":"2024","unstructured":"Dawson LA, Ringash J, Fairchild A, Stos P, Dennis K, Mahmud A, Stuckless TL, Vincent F, Roberge D, Follwell M, Wong RKW, Jonker DJ, Knox JJ, Zimmermann C, Wong P, Barry AS, Gaudet M, Wong RKS, Purdie TG, Tu D and O’Callaghan CJ. Palliative radiotherapy versus best supportive care in patients with painful hepatic cancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 study. Lancet Oncol 2024; 25: 1337-1346.","journal-title":"Lancet Oncol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.2147\/IJGM.S403316","article-title":"Evaluation of the clinical efficacy of intensity-modulated radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma with extrahepatic oligometastasis and prognostic factors for patient survival","volume":"16","author":"Luo","year":"2023","unstructured":"Luo Y, Huang X, Chen J and Zhang S. Evaluation of the clinical efficacy of intensity-modulated radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma with extrahepatic oligometastasis and prognostic factors for patient survival. Int J Gen Med 2023; 16: 1271-1278.","journal-title":"Int J Gen Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2147\/JHC.S361045","article-title":"Skull base metastasis from hepatocellular carcinoma: clinical presentation and efficacy of radiotherapy","volume":"9","author":"Kim","year":"2022","unstructured":"Kim K, Lee J and Seong J. Skull base metastasis from hepatocellular carcinoma: clinical presentation and efficacy of radiotherapy. J Hepatocell Carcinoma 2022; 9: 357-366.","journal-title":"J Hepatocell Carcinoma"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12951-025-03133-3","article-title":"Radiotherapy plus a self-gelation powder encapsulating tRF5-GlyGCC inhibitor potentiates natural kill cell immunity to prevent hepatocellular carcinoma recurrence","volume":"23","author":"Gong","year":"2025","unstructured":"Gong Y, Zeng F, Zhang F, Liu X, Li Z, Chen W, Liu H, Li X, Cheng Y, Zhang J, Feng Y, Wu T, Zhou W and Zhang T. Radiotherapy plus a self-gelation powder encapsulating tRF5-GlyGCC inhibitor potentiates natural kill cell immunity to prevent hepatocellular carcinoma recurrence. J Nanobiotechnology 2025; 23: 100.","journal-title":"J Nanobiotechnology"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Sarwar A, Malik MS, Vo NH, Tsai LL, Tahir MM, Curry MP, Catana AM, Bullock AJ, Parker JA, Eckhoff DE, Nasser IA, Weinstein JL and Ahmed M. Efficacy and safety of radiation segmentectomy with (90)Y resin microspheres for hepatocellular carcinoma. Radiology 2024; 311: e231386.","DOI":"10.1148\/radiol.231386"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Ferini G, Palmisciano P, Scalia G, Haider AS, Bin-Alamer O, Sagoo NS, Bozkurt I, Deora H, Priola SM, Aoun SG and Umana GE. The role of radiation therapy in the treatment of spine metastases from hepatocellular carcinoma: a systematic review and meta-analysis. Neurosurg Focus 2022; 53: E12.","DOI":"10.3171\/2022.8.FOCUS2255"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Chen CY, Huang BS, Hong JH, Chang JT, Chen MC, Tang WR, Shun SC and Chen ML. Persistent fatigue in patients with hepatocellular carcinoma receiving radiotherapy. J Nurs Res 2024; 32: e319.","DOI":"10.1097\/jnr.0000000000000606"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/9\/ajtr0166093.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T02:50:57Z","timestamp":1769050257000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/9\/ajtr0166093.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/hrdh6927","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}